These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10202617)

  • 1. Improving the therapeutic monitoring of cyclosporin A.
    Warrens AN; Waters JB; Salama AD; Lechler RI
    Clin Transplant; 1999 Apr; 13(2):193-200. PubMed ID: 10202617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.
    Kelles A; Herman J; Tjandra-Maga TB; Van Damme-Lombaerts R
    Pediatr Transplant; 1999 Nov; 3(4):282-7. PubMed ID: 10562972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis.
    Internation Neoral Renal Transplantation Study Group
    Am J Transplant; 2002 Feb; 2(2):157-66. PubMed ID: 12099518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin C2hour monitoring after renal transplantation.
    Einecke G; Mai I; Fritsche L; Slowinski T; Waiser J; Glander P; Böhler T; Neumayer HH; Budde K
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):477-81. PubMed ID: 14703954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.
    Weber LT; Armstrong VW; Shipkova M; Feneberg R; Wiesel M; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B;
    Ther Drug Monit; 2004 Aug; 26(4):415-24. PubMed ID: 15257072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.
    International Neoral Renal Transplantation Study Group.
    Am J Transplant; 2002 Feb; 2(2):148-56. PubMed ID: 12099517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Neoral study group.
    Marsh CL
    Ther Drug Monit; 1999 Feb; 21(1):27-34. PubMed ID: 10051051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
    Thomas DW; Baboolal K; Subramanian N; Newcombe RG
    J Clin Periodontol; 2001 Jul; 28(7):706-9. PubMed ID: 11422595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
    Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
    Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8).
    Grant D; Kneteman N; Tchervenkov J; Roy A; Murphy G; Tan A; Hendricks L; Guilbault N; Levy G
    Transplantation; 1999 Apr; 67(8):1133-7. PubMed ID: 10232563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoral monitoring by limited sampling area under the concentration time curve in stable indian renal transplant recipients.
    Jaiswal J; Gupta SK; Dash SC; Tiwari SC; Mehta SN; Gupta YK; Velpandian T
    Transplant Proc; 2003 Jun; 35(4):1298-9. PubMed ID: 12826142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications in cyclosporine (CsA) microemulsion blood concentrations by olestra.
    Terrill CJ; Lill J; Somerville KT; Sherbotie JR
    J Ren Nutr; 2003 Jan; 13(1):26-30. PubMed ID: 12563620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.